These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37864176)

  • 1. In Vitro antibiotic combinations of Colistin, Meropenem, Amikacin, and Amoxicillin/clavulanate against multidrug-resistant Klebsiella pneumonia isolated from patients with ventilator-associated pneumonia.
    Bayatinejad G; Salehi M; Beigverdi R; Halimi S; Emaneini M; Jabalameli F
    BMC Microbiol; 2023 Oct; 23(1):298. PubMed ID: 37864176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergetic Effects of Combined Treatment of Colistin With Meropenem or Amikacin on Carbapenem-Resistant
    Yu L; Zhang J; Fu Y; Zhao Y; Wang Y; Zhao J; Guo Y; Li C; Zhang X
    Front Cell Infect Microbiol; 2019; 9():422. PubMed ID: 31921701
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Goel A; Gupta V; Singhal L; Palta S; Chander J
    Indian J Med Res; 2021 Mar; 154(3):520-526. PubMed ID: 35345078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isothermal microcalorimetry vs checkerboard assay to evaluate in-vitro synergism of meropenem-amikacin and meropenem-colistin combinations against multi-drug-resistant Gram-negative pathogens.
    Antonelli A; Coppi M; Tellapragada C; Hasan B; Maruri A; Gijón D; Morecchiato F; de Vogel C; Verbon A; van Wamel W; Kragh KN; Frimodt-Møller N; Cantón R; Giske CG; Rossolini GM
    Int J Antimicrob Agents; 2022 Oct; 60(4):106668. PubMed ID: 36038097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Synergy of Ceftazidime-Avibactam in Combination with Meropenem, Amikacin, Aztreonam, Colistin, or Fosfomycin against Well-Characterized Multidrug-Resistant Klebsiella pneumoniae and Pseudomonas aeruginosa.
    Mikhail S; Singh NB; Kebriaei R; Rice SA; Stamper KC; Castanheira M; Rybak MJ
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of In Vitro Efficacy of Ceftazidime-Avibactam, Meropenem, and Colistin Single and Binary Combinations Against Carbapenem Resistant Klebsiella pneumoniae Strains Isolated from Various Clinical Specimens].
    Köle M; Sesli Çetin E; Şirin MC; Cicioğlu Arıdoğan B
    Mikrobiyol Bul; 2022 Apr; 56(2):230-250. PubMed ID: 35477227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro synergistic activity of fosfomycin in combination with meropenem, amikacin and colistin against OXA-48 and/or NDM-producing
    Erturk Sengel B; Altinkanat Gelmez G; Soyletir G; Korten V
    J Chemother; 2020 Sep; 32(5):237-243. PubMed ID: 32228228
    [No Abstract]   [Full Text] [Related]  

  • 8. In-vitro synergistic activity of colistin and meropenem against clinical isolates of carbapenem resistant E.coli and Klebsiella pneumoniae by checkerboard method.
    Dhandapani S; Sistla S; Gunalan A; Manoharan M; Sugumar M; Sastry AS
    Indian J Med Microbiol; 2021 Jan; 39(1):6-10. PubMed ID: 33516606
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Copur B; Dosler S; Aktas Z; Basaran S; Simsek-Yavuz S; Cagatay A; Oncul O; Ozsut H; Eraksoy H
    Future Microbiol; 2022 Sep; 17():1027-1042. PubMed ID: 35796076
    [No Abstract]   [Full Text] [Related]  

  • 10. Time kill-assays of antibiotic combinations for multidrug resistant clinical isolates of OXA-48 carbapenemase producing Klebsiella pneumoniae.
    Erdem F; Díez-Aguilar M; Oksuz L; Kayacan C; Abulaila A; Oncul O; Morosini MI; Cantón R; Aktas Z
    Acta Microbiol Immunol Hung; 2022 Sep; 69(3):215-219. PubMed ID: 35895557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency Determination of Carbapenem-Resistant Klebsiella Pneumoniae (CRKP) Isolated from hospitals in Isfahan of Iran and Evaluation of Synergistic Effect of Colistin and Meropenem on them.
    Gheitani L; Fazeli H; Moghim S; Nasr Isfahani B
    Cell Mol Biol (Noisy-le-grand); 2018 Jan; 64(1):70-74. PubMed ID: 29412797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrastructural changes caused by the combination of intravenous immunoglobulin with meropenem, amikacin and colistin in multidrug-resistant Acinetobacter baumannii.
    Lima FCG; Oliveira-Júnior JB; Cavalcanti CLB; Veras DL; Freitas CF; Sandes JM; da Silva EM; da Rocha DAM; Alves LC; Brayner FA
    Microb Pathog; 2020 Dec; 149():104437. PubMed ID: 33045338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of In vitro Efficacy of Meropenem/Colistin and Meropenem/Fosfomycin Combinations on Multidrug Resistant Gram-Negative Bacilli].
    Adaleti R; Nakipoğlu Y; Arıcı N; Kansak N; Çalık Ş; Şenbayrak S; Balık R; Aksaray S
    Mikrobiyol Bul; 2023 Jul; 57(3):365-377. PubMed ID: 37462301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-Dependent Synergistic Interactions of Colistin with Rifampin, Meropenem, and Tigecycline against Carbapenem-Resistant Klebsiella pneumoniae Biofilms.
    Geladari A; Simitsopoulou M; Antachopoulos C; Roilides E
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic antibacterial effects of colistin in combination with aminoglycoside, carbapenems, cephalosporins, fluoroquinolones, tetracyclines, fosfomycin, and piperacillin on multidrug resistant Klebsiella pneumoniae isolates.
    Ontong JC; Ozioma NF; Voravuthikunchai SP; Chusri S
    PLoS One; 2021; 16(1):e0244673. PubMed ID: 33406110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tigecycline in combination with other antibiotics against clinical isolates of carbapenem-resistant Klebsiella pneumoniae in vitro.
    Zhang J; Yu L; Fu Y; Zhao Y; Wang Y; Zhao J; Guo Y; Li C; Zhang X
    Ann Palliat Med; 2019 Nov; 8(5):622-631. PubMed ID: 31735038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates.
    Gaibani P; Lombardo D; Lewis RE; Mercuri M; Bonora S; Landini MP; Ambretti S
    J Antimicrob Chemother; 2014 Jul; 69(7):1856-65. PubMed ID: 24648503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective, comparative clinical study between high-dose colistin monotherapy and colistin-meropenem combination therapy for treatment of hospital-acquired pneumonia and ventilator-associated pneumonia caused by multidrug-resistant Klebsiella pneumoniae.
    Abdelsalam MFA; Abdalla MS; El-Abhar HSE
    J Glob Antimicrob Resist; 2018 Dec; 15():127-135. PubMed ID: 30010061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic antibiotic combinations for colistin-resistant Klebsiella pneumoniae.
    Kádár B; Kocsis B; Tóth Á; Damjanova I; Szász M; Kristóf K; Nagy K; Szabó D
    Acta Microbiol Immunol Hung; 2013 Jun; 60(2):201-9. PubMed ID: 23827751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of double carbapenem and colistin combinations against OXA-48, NDM carbapenemase-producing colistin-resistant Klebsiella pneumoniae strains.
    Erdem F; Abulaila A; Aktas Z; Oncul O
    Antimicrob Resist Infect Control; 2020 May; 9(1):70. PubMed ID: 32430058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.